Detalles de la búsqueda
1.
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 436, 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38589856
2.
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 23(7): 876-887, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35636444
3.
Efficacy and safety of trabectedin for the treatment of advanced uterine or ovarian carcinosarcoma: Results of a phase II multicenter clinical trial (MITO-26).
Gynecol Oncol
; 167(3): 436-443, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36220670
4.
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(10): 1458-1467, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543613
5.
Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancer.
BMC Cancer
; 21(1): 611, 2021 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34034685
6.
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group.
Cancer
; 126(21): 4726-4734, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32749681
7.
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis.
Oncologist
; 25(6): e928-e935, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31943506
8.
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
BMC Cancer
; 20(1): 683, 2020 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32698790
9.
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 563, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38711003
10.
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
BMC Cancer
; 19(1): 283, 2019 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30922323
11.
Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC-IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional Study.
Int J Gynecol Cancer
; 28(9): 1706-1713, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30376554
12.
The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study.
Int J Gynecol Cancer
; 27(9): 1856-1862, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29064913
13.
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19).
Gynecol Oncol
; 143(3): 532-538, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27717490
14.
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial.
Lancet Oncol
; 16(5): 561-8, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25882986
15.
eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial.
J Transl Med
; 13: 258, 2015 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-26259598
16.
Prophylaxis and treatment of peritoneal carcinomatosis of gastric origin using hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis of randomized trials.
J Gastrointest Surg
; 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38599315
17.
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial.
J Clin Oncol
; 42(13): 1488-1498, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38315944
18.
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study.
J Clin Oncol
; 42(11): 1278-1287, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181312
19.
Recurrent granulosa cell tumors (GCTs) of the ovary: a MITO-9 retrospective study.
Gynecol Oncol
; 130(1): 38-42, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23623833
20.
Frailty assessment can predict textbook outcomes in senior adults after minimally invasive colorectal cancer surgery.
Eur J Surg Oncol
; 49(3): 626-632, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36396488